Drugs duo to merge

HALF of all generic prescriptions could come from one supplier after the nation’s competition watchdog approved a merger between two pharmaceutical companies.

India’s Strides Pharma Science, operating in Australia and New Zealand as Arrow Pharmaceuticals, is seeking to merge with the local arm of Toronto-based company Apotex.

The Australian Competition and Consumer Commission has ruled the new entity will not hurt competition.